Development of a Vaccine against Murine Cytomegalovirus (MCMV), Consisting of Plasmid DNA and Formalin-Inactivated MCMV, That Provides Long-Term, Complete Protection against Viral Replication
Open Access
- 15 May 2002
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 76 (10) , 4822-4835
- https://doi.org/10.1128/jvi.76.10.4822-4835.2002
Abstract
We previously demonstrated that immunization of mice with plasmid DNAs (pDNAs) expressing the murine cytomegalovirus (MCMV) genes IE1-pp89 and M84 provided synergistic protection against sublethal viral challenge, while immunization with plasmids expressing putative virion proteins provided no or inconsistent protection. In this report, we sought to augment protection by increasing the breadth of the immune response. We identified another MCMV gene (m04 encoding gp34) that provided strong and consistent protection against viral replication in the spleen. We also found that immunization with a DNA pool containing 10 MCMV genes that individually were nonprotective elicited reproducible protection against low to intermediate doses of challenge virus. Moreover, inclusion of these plasmids into a mixture with gp34, pp89, and M84 DNAs provided even greater protection than did coimmunization with pp89 and M84. The highest level of protection was achieved by immunization of mice with the pool of 13 pDNAs, followed by formalin-inactivated MCMV (FI-MCMV). Immunization with FI-MCMV elicited neutralizing antibodies against salivary gland-derived MCMV, and of greatest importance, mice immunized with both the combined pDNA pool and FI-MCMV had undetectable levels of virus in the spleen and salivary glands after challenge. Intracellular cytokine staining of splenocytes from pDNA- and FI-MCMV-immunized mice showed that pDNA immunization elicited high levels of pp89- and M83-specific CD8+ T cells, whereas both pDNA and FI-MCMV immunizations generated strong CD8+-T-cell responses against virion-associated antigens. Taken together, these results show that immunization with pDNA and inactivated virus provides strong antibody and cell-mediated immunity against CMV infection.Keywords
This publication has 78 references indexed in Scilit:
- Dynamics of T Lymphocyte Responses: Intermediates, Effectors, and Memory CellsScience, 2000
- Assessment of antigenicity and genetic variation of glycoprotein B of murine cytomegalovirusJournal of General Virology, 1996
- Protection Against Murine Cytomegalovirus Infection by Passive Transfer of Neutralizing and Non-Neutralizing Monoclonal AntibodiesJournal of General Virology, 1991
- Cytolytic T lymphocyte recognition of the murine cytomegalovirus nonstructural immediate-early protein pp89 expressed by recombinant vaccinia virus.The Journal of Experimental Medicine, 1987
- A nonstructural polypeptide encoded by immediate-early transcription unit 1 of murine cytomegalovirus is recognized by cytolytic T lymphocytes.The Journal of Experimental Medicine, 1987
- Significance of herpesvirus immediate early gene expression in cellular immunity to cytomegalovirus infectionNature, 1984
- The cytolytic T lymphocyte response to the murine cytomegalovirus. II. Detection of virus replication stage‐specific antigens by separate populations of in vivo active cytolytic T lymphocyte precursorsEuropean Journal of Immunology, 1984
- Modification by Adoptive Humoral Immunity of Murine Cytomegalovirus InfectionThe Journal of Infectious Diseases, 1981
- Inactivated Mouse Cytomegalovirus Vaccine: Preparation, Immunogenicity, and Protective EffectThe Journal of Infectious Diseases, 1980
- Cytotoxic T lymphocyte response to murine cytomegalovirus infectionNature, 1978